Inactive Instrument
ARYx Therapeutics, Inc. Share Price Other OTC
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 90.35L 79.03L 72.89L 67.32L 1.28Cr 86Cr 1.3Cr 8.71Cr 3.42Cr 42Cr 3.39Cr 3.32Cr 145.93Cr | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 1.14Cr 99.77L 92.02L 84.99L 1.61Cr 108.78Cr 1.64Cr 11Cr 4.32Cr 54Cr 4.28Cr 4.19Cr 184.23Cr | EV / Sales 2008 |
40,19,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 1 day | +47.06% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +47.06% | +4.62% | - | - | 33 | ||
| -2.48% | -3.13% | +55.85% | +89.65% | 5.49TCr | ||
| -0.55% | -6.57% | +55.85% | +128.31% | 5.46TCr | ||
| -5.09% | -1.69% | +7.63% | +422.94% | 2.51TCr | ||
| -0.45% | -2.82% | -17.77% | -16.65% | 2.31TCr | ||
| -1.69% | -0.64% | +40.04% | -0.48% | 1.99TCr | ||
| +1.87% | +4.16% | +38.74% | -26.42% | 1.75TCr | ||
| -2.72% | -0.60% | +187.08% | +351.91% | 1.65TCr | ||
| -2.42% | +1.00% | +48.24% | +635.77% | 1.57TCr | ||
| -1.19% | +0.50% | +22.44% | +188.42% | 1.42TCr | ||
| Average | +3.23% | -0.82% | +48.68% | +197.05% | 2.68TCr | |
| Weighted average by Cap. | -1.68% | -1.56% | +47.76% | +166.27% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.25 15.91 14.7 27.89 1.88T 28.36 190.14 74.67 926.72 74.06 72.45 3.19T | - |
| Net income | -3.12Cr -2.73Cr -2.52Cr -2.33Cr -4.41Cr -297.74Cr -4.49Cr -30Cr -12Cr -146.68Cr -12Cr -11Cr -504.24Cr | -3.32Cr -2.9Cr -2.68Cr -2.47Cr -4.69Cr -316.33Cr -4.77Cr -32Cr -13Cr -155.83Cr -12Cr -12Cr -535.72Cr |
| Net Debt | -29.9 -26.16 -24.13 -22.28 -42.28 -2.85T -42.99 -288.28 -113.21 -1.41T -112.28 -109.84 -4.83T | 2.37 2.07 1.91 1.77 3.35 226.13 3.41 22.86 8.98 111.4 8.9 8.71 382.97 |
Employees
-
















